Free Trial

Envista Holdings Co. (NYSE:NVST) Shares Bought by Two Sigma Advisers LP

Envista logo with Medical background

Two Sigma Advisers LP increased its holdings in Envista Holdings Co. (NYSE:NVST - Free Report) by 66.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 47,800 shares of the company's stock after acquiring an additional 19,100 shares during the period. Two Sigma Advisers LP's holdings in Envista were worth $922,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. Tidal Investments LLC boosted its position in shares of Envista by 53.9% during the fourth quarter. Tidal Investments LLC now owns 31,307 shares of the company's stock worth $604,000 after buying an additional 10,958 shares during the period. Polar Asset Management Partners Inc. raised its stake in shares of Envista by 27.9% in the fourth quarter. Polar Asset Management Partners Inc. now owns 1,914,799 shares of the company's stock valued at $36,936,000 after acquiring an additional 417,549 shares in the last quarter. Quantinno Capital Management LP raised its stake in shares of Envista by 54.2% in the fourth quarter. Quantinno Capital Management LP now owns 86,056 shares of the company's stock valued at $1,660,000 after acquiring an additional 30,264 shares in the last quarter. LMR Partners LLP acquired a new stake in shares of Envista in the fourth quarter valued at $5,037,000. Finally, Iron Triangle Partners LP raised its stake in shares of Envista by 0.5% in the fourth quarter. Iron Triangle Partners LP now owns 2,200,000 shares of the company's stock valued at $42,438,000 after acquiring an additional 10,631 shares in the last quarter.

Envista Stock Performance

Shares of Envista stock traded down $0.07 on Thursday, hitting $18.69. The stock had a trading volume of 1,189,539 shares, compared to its average volume of 2,567,551. Envista Holdings Co. has a 52-week low of $14.22 and a 52-week high of $23.00. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of -2.88, a P/E/G ratio of 1.27 and a beta of 0.99. The company's 50 day moving average price is $16.75 and its 200 day moving average price is $18.70.

Envista (NYSE:NVST - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.04. The business had revenue of $616.90 million during the quarter, compared to the consensus estimate of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The business's quarterly revenue was down 1.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.26 EPS. On average, research analysts anticipate that Envista Holdings Co. will post 1 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on NVST shares. New Street Research set a $19.00 price objective on Envista in a research note on Thursday, March 6th. Morgan Stanley set a $16.00 price objective on Envista in a research note on Tuesday, April 15th. Piper Sandler reduced their price objective on Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Baird R W raised Envista from a "hold" rating to a "strong-buy" rating in a report on Tuesday, May 27th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Envista in a report on Thursday, March 6th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $20.23.

Read Our Latest Report on NVST

Envista Profile

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Featured Articles

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines